Chongqing Minimally Invasive Treatment Research Center for External Genital Diseases
Chongqing Minimally Invasive Treatment Research Center for Benign Uterine Diseases
On Oct 13, an unusual operation for uterine fibroids was in progress in Chris Hani Bara Hospital of South Africa. Under the guidance of Dr. Deng Yongbin from Chongqing Haifu Hospital, the first case of HIFU ablation of uterine fibroids was completed successfully, which ushers a new era in South African medical history.
According to the local doctors, South African women are reluctant to receive hysterectomy because the more children they give birth to, the higher their position in the family will be. The treated patient, 41 years old, has suffered multiple uterine fibroids for many years, with the diameter of the biggest fibroid of about 6 cm and that of the two smaller ones of about 3 cm. The treatment was finished 82 minutes later with satisfactory ablated area showed by CDFI. After the treatment, the lady was interviewed sitting on bed. When asked about the trouble brought by uterine fibroids, she shed tears saying “I don’t have to suffer from uterine fibroids anymore!”
According to the local doctors, South African women are reluctant to receive hysterectomy because the more children they give birth to, the higher their position in the family will be. The treated patient, 41 years old, has suffered multiple uterine fibroids for many years, with the diameter of the biggest fibroid of about 6 cm and that of the two smaller ones of about 3 cm. The treatment was finished 82 minutes later with satisfactory ablated area showed by CDFI. After the treatment, the lady was interviewed sitting on bed. When asked about the trouble brought by uterine fibroids, she shed tears saying “I don’t have to suffer from uterine fibroids anymore!”
After treatment, Dr. Deng Yongbi, the spokesman of Ministry of Healthfrom Gauteng province in South Africa, and the patient were interviewed by local media. "It's so exciting!" said the spokesman of Ministry of Health. The ultrasonic tumor therapeutic technology will greatly improve the cure rate of patients with uterine fibroids and relieve the pain of patients.
Brief introduction of Dr. Deng Yongbin